Membio
A leader in single-use bioreactor technology
* Data source: Crunchbase
- Founded
- 2018
- Employees*
- 1-10
- Funding to Date*
- $23K
- Website
- membio.ca
The underlying scientific principles that make unprecedented commercial-scale production of red blood cells possible also make the unprecedented commercial-scale production of other whole cell produts possible as well. Membio's biomanufacturing platform has the potential to radically change the entire cell and gene therapy industy!
Every 2 seconds someone in the U.S. needs blood.
Membio is developing a world class biomanufacturing platform to enable the cost-effective and scalable production of whole cells, including red blood cells. Blood is a necessary prerequisite for many life-saving interventions, making a reliable blood supply an essential part of any healthcare system. Membio is on a mission to provide the world with a safe and sustainable supply of blood.
